| 5-Amino-1MQ Quinolinium Salt, 50 mg Lyophilized Vial | AM-2609-27 | 2026-09-16 | 99.8% (HPLC) | PDF |
| AOD-9604 Lyophilized Powder, 5 mg Vial, ≥99% HPLC | AO-2609-01 | 2026-09-02 | 99.8% (HPLC) | PDF |
| Bioglutide 10 mg Lyophilized Acylated Peptide Analogue Vial | BG-2609-26 | 2026-09-16 | 99.3% (HPLC) | PDF |
| BPC-157 Lyophilized Powder, 10 mg per Vial | BP-2609-25 | 2026-09-12 | 99.7% (HPLC) | PDF |
| BPC-157 Lyophilized Powder, 5 mg Vial | BP-2609-16 | 2026-09-12 | 99.7% (HPLC) | PDF |
| CJC-1295 with DAC 5 mg Lyophilized Vial | CJ-2609-30 | 2026-09-17 | 99.3% (HPLC) | PDF |
| CJC-1295 with DAC, 2 mg Lyophilized Vial | CJ-2609-15 | 2026-09-11 | 99.3% (HPLC) | PDF |
| CJC-1295 Without DAC, 10 mg Lyophilized Vial | CJ-2609-29 | 2026-09-17 | 99.7% (HPLC) | PDF |
| Co-Lyophilized BPC-157 and TB-500 Blend, 5 mg + 5 mg | BT-2609-28 | 2026-09-17 | 99.8% (HPLC) | PDF |
| DSIP Synthetic Nonapeptide, 10 mg Lyophilized Vial | DS-2609-31 | 2026-09-18 | 99.7% (HPLC) | PDF |
| Epitalon Tetrapeptide, 10 mg Lyophilized Vial | EP-2609-02 | 2026-09-03 | 99.7% (HPLC) | PDF |
| GHK-Cu Copper Tripeptide, 100 mg Lyophilized Vial | GK-2609-32 | 2026-09-18 | 99.8% (HPLC) | PDF |
| GHK-Cu Copper Tripeptide, 50 mg Lyophilized Vial | GK-2609-17 | 2026-09-12 | 99.7% (HPLC) | PDF |
| GHRP-2 Lyophilized Hexapeptide, 5 mg Vial | GH-2609-19 | 2026-09-13 | 99.7% (HPLC) | PDF |
| GLOW Co-Lyophilized Blend, 70 mg per Vial | GL-2609-33 | 2026-09-18 | 99.3% (HPLC) | PDF |
| Glutathione 1500 mg Lyophilized Powder, ≥99% by HPLC | GS-2609-35 | 2026-09-19 | 99.3% (HPLC) | PDF |
| Glutathione 600 mg Lyophilized Powder, ≥99% by HPLC | GS-2609-34 | 2026-09-19 | 99.7% (HPLC) | PDF |
| HCG Glycoprotein, 5000 IU Lyophilized Vial | HC-2609-18 | 2026-09-13 | 99.7% (SDS-PAGE) | PDF |
| IGF-1 LR3 Recombinant Analogue, 1 mg Lyophilized Vial | IG-2609-20 | 2026-09-14 | 99.3% (SDS-PAGE) | PDF |
| Ipamorelin Pentapeptide, 10 mg Lyophilized Vial | IP-2609-36 | 2026-09-19 | 99.3% (HPLC) | PDF |
| Ipamorelin Pentapeptide, 5 mg Lyophilized Vial | IP-2609-21 | 2026-09-14 | 99.7% (HPLC) | PDF |
| Kisspeptin-10 Lyophilized Powder, 10 mg Vial | KP-2609-37 | 2026-09-20 | 99.7% (HPLC) | PDF |
| KLOW Co-Lyophilized Blend, 80 mg per Vial | KL-2609-38 | 2026-09-20 | 99.3% (HPLC) | PDF |
| KPV Tripeptide, 10 mg Lyophilized Vial, ≥99% HPLC | KV-2609-39 | 2026-09-20 | 99.8% (HPLC) | PDF |
| Melanotan II, 10 mg Lyophilized Vial, ≥99% HPLC | ME-2609-23 | 2026-09-15 | 99.3% (HPLC) | PDF |
| MOTS-c 10 mg Lyophilized Peptide Vial, ≥99% by HPLC | MC-2609-40 | 2026-09-21 | 99.7% (HPLC) | PDF |
| MOTS-c 20 mg Lyophilized Vial, ≥99% by HPLC | MC-2609-41 | 2026-09-21 | 99.3% (HPLC) | PDF |
| MOTS-c 40 mg Lyophilized Powder, 16-Amino-Acid Peptide Vial | MC-2609-42 | 2026-09-21 | 99.7% (HPLC) | PDF |
| NAD+ Lyophilized Powder, 1000 mg per Vial | ND-2609-44 | 2026-09-21 | 99.8% (HPLC) | PDF |
| Nicotinamide Adenine Dinucleotide (NAD+), 500 mg Lyophilized Vial | ND-2609-43 | 2026-09-21 | 99.8% (HPLC) | PDF |
| PT-141 Cyclic Heptapeptide, 10 mg Lyophilized Vial | PT-2609-50 | 2026-09-23 | 99.3% (HPLC) | PDF |
| Recombinant Follistatin Protein, 1 mg Lyophilized Vial | FS-2609-03 | 2026-09-04 | 99.7% (SDS-PAGE) | PDF |
| RT10 Multi-Receptor Agonist Peptide, 10 mg Vial | RE-2609-04 | 2026-09-05 | 99.7% (HPLC) | PDF |
| RT20 Synthetic Multi-Receptor Agonist Peptide, 20 mg Vial | RT-2609-45 | 2026-09-22 | 99.3% (HPLC) | PDF |
| RT30 Synthetic Multi-Receptor Agonist Peptide, 30 mg Vial | RT-2609-05 | 2026-09-05 | 99.8% (HPLC) | PDF |
| Selank Synthetic Heptapeptide, 10 mg Lyophilized Vial | SL-2609-46 | 2026-09-22 | 99.3% (HPLC) | PDF |
| Semax Heptapeptide, 10 mg Lyophilized Vial | SX-2609-47 | 2026-09-22 | 99.3% (HPLC) | PDF |
| Sermorelin (GHRH 1–29), 2 mg Lyophilized Vial | SE-2609-48 | 2026-09-22 | 99.8% (HPLC) | PDF |
| Sermorelin 5 mg Lyophilized Powder Vial, ≥99% HPLC | SE-2609-06 | 2026-09-06 | 99.8% (HPLC) | PDF |
| SLU-PP-332 Small-Molecule Research Compound, 5 mg Lyophilized Vial | SU-2609-52 | 2026-09-23 | 99.8% (HPLC) | PDF |
| SM10 Acylated Peptide Analogue, 10 mg Lyophilized Vial | SM-2609-07 | 2026-09-07 | 99.3% (HPLC) | PDF |
| SM5 Acylated Peptide Analogue, 5 mg Lyophilized Vial | SM-2609-22 | 2026-09-15 | 99.3% (HPLC) | PDF |
| SS-31 Aromatic-Cationic Tetrapeptide, 50 mg Lyophilized Vial | SS-2609-51 | 2026-09-23 | 99.8% (HPLC) | PDF |
| Sterile 10 mL Borosilicate Glass Vials, Box of 10 | VL-2607-08 | 2026-07-30 | — | PDF |
| Sterile Bacteriostatic Water with 0.9% Benzyl Alcohol, 30 mL | BW-2608-19 | 2026-08-25 | — | PDF |
| TB-500 Lyophilized Powder, 10 mg Vial, ≥99% HPLC | TB-2609-49 | 2026-09-22 | 99.7% (HPLC) | PDF |
| TB-500 Synthetic Thymosin Beta-4 Fragment, 5 mg Vial | TB-2609-24 | 2026-09-16 | 99.3% (HPLC) | PDF |
| Tesamorelin 10 mg Lyophilized GHRH Analogue Vial | TE-2609-08 | 2026-09-08 | 99.7% (HPLC) | PDF |
| Tesamorelin 5 mg Lyophilized GHRH Analogue Vial | TE-2609-09 | 2026-09-08 | 99.8% (HPLC) | PDF |
| Thymosin Peptide, 10 mg Lyophilized Vial | TH-2609-10 | 2026-09-09 | 99.7% (HPLC) | PDF |
| TZ-2 Acylated Peptide Analogue, 10 mg Lyophilized Vial | TZ-2609-14 | 2026-09-11 | 99.8% (HPLC) | PDF |
| TZ-2 Acylated Peptide, 5 mg Lyophilized Vial | TZ-2609-12 | 2026-09-10 | 99.8% (HPLC) | PDF |
| TZ10 Acylated Peptide Analogue, 10 mg Lyophilized Vial | TZ-2609-13 | 2026-09-10 | 99.8% (HPLC) | PDF |
| TZ5 Acylated Peptide Analogue, 5 mg Lyophilized Vial | TZ-2609-11 | 2026-09-09 | 99.8% (HPLC) | PDF |
Next upLab SuppliesBrowse the category →